| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |